# Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)

> **NCT07671365** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Methodist Healthcare System of San Antonio** · enrollment: 329 (estimated)

## Conditions studied

- Vasoplegic Shock
- Cardiopulmonary Bypass
- Vasoplegia

## Interventions

- **DRUG:** Angiotensin II (Giapreza®)

## Key facts

- **NCT ID:** NCT07671365
- **Lead sponsor:** Methodist Healthcare System of San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2029-07
- **Final completion:** 2030-08
- **Target enrollment:** 329 (ESTIMATED)
- **Last updated:** 2026-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07671365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07671365, "Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07671365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*